Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Benjamin Halladay > Profile

Benjamin Halladay

Affiliations

Chief Financial Officer at Esperion Therapeutics Inc. (ESPR), 2024-12-18

Insider Trading: Sales See All

Company	Symbol	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Esperion Therapeutics Inc.	ESPR	$2.42	3,245	Officer	240,691	2024-12-17	Filing